Clinical Trial

ASTHMAXcel Voice Study

Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this study is to conduct a randomized controlled trial (RCT) to compare the adapted and refined ASTHMAXcel Voice platform to usual care (UC). It is hypothesized by the investigator team that ASTHMAXcel Voice will be associated with improved clinical and process outcomes, asthma quality of life (QOL), medication adherence, and self-efficacy as compared to UC.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-04-11; most recent amendment 2025-10-22.
Status change: Not Yet Recruiting → Recruiting 2025-10-22
Trial Details
NCT Number NCT06935084
Lead Sponsor Montefiore Medical Center
Collaborators: Yeshiva University, Agency for Healthcare Research and Quality (AHRQ)
Conditions Asthma
Enrollment 200 participants
Start Date 2025-09-18
Primary Completion 2028-09 (estimated)
Study Completion 2028-09 (estimated)
Updated on ClinicalTrials.gov 2025-10-24